-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Entrada Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q3 2020 to Q2 2025.
- Entrada Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending June 30, 2025 was 41.3M shares, a 16.4% increase year-over-year.
- Entrada Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 39M shares, a 18% increase from 2023.
- Entrada Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 33.1M shares, a 5.62% increase from 2022.
- Entrada Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 31.3M shares, a 399% increase from 2021.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)